Evidence map›Paper›PMID 28446573›Full record

ArticleJournal of clinical microbiology2017

Serologic Testing for Zika Virus: Comparison of Three Zika Virus IgM-Screening Enzyme-Linked Immunosorbent Assays and Initial Laboratory Experiences.

Dane Granger, Heather Hilgart, Lori Misner, Jaime Christensen, Sarah Bistodeau, Jennifer Palm, Anna K Strain, Marja Konstantinovski, Dakai Liu, Anthony Tran and 1 more

Open access · bronzeAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Arboviruses and pregnancy: are the threats visible or hidden?Tropical diseases, travel medicine and vaccines · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Zika virus serological diagnosis: commercial tests and monoclonal antibodies as tools.The journal of venomous animals and toxins including tropical diseases · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Early Clinical Infancy Outcomes for Microcephaly and/or Small for Gestational Age Zika-Exposed Infants.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Dane GrangerDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Heather HilgartDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Lori MisnerDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Jaime ChristensenMinnesota Department of Health, St. Paul, Minnesota, USA.
Sarah BistodeauMinnesota Department of Health, St. Paul, Minnesota, USA.
Jennifer PalmMinnesota Department of Health, St. Paul, Minnesota, USA.
Anna K StrainMinnesota Department of Health, St. Paul, Minnesota, USA.
Marja KonstantinovskiNew York City Department of Health and Mental Hygiene, Bureau of Public Health Laboratory, New York City, New York, USA.
Dakai LiuNew York City Department of Health and Mental Hygiene, Bureau of Public Health Laboratory, New York City, New York, USA.
Anthony TranNew York City Department of Health and Mental Hygiene, Bureau of Public Health Laboratory, New York City, New York, USA.
Elitza S TheelDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA theel.elitza@mayo.edu.
Mayo Clinic · USMinnesota Department of Health · USNew York City Department of Health and Mental Hygiene · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serologic evaluation for Zika virus (ZIKV) infection currently includes an initial screen using an anti-ZIKV IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) followed by supplemental testing of specimens with nonnegative results by a plaque reduction neutralization test (PRNT). We compared the performance characteristics of three ELISAs for the detection of IgM class antibodies to ZIKV, including the Centers for Disease Control and Prevention (CDC) Zika MAC-ELISA, the InBios ZIKV

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, ViralChildChild, PreschoolEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin MImmunologic FactorsInfantInfant, NewbornMaleMiddle AgedAntibodies, ViralImmunoglobulin MImmunologic FactorsserologyZika virus

Identifiers

PMID28446573
PMCPMC5483914
OpenAlexW2608731112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.